Mechanisms of VIP-induced inhibition of the lymphatic vessel pump

Journal of Physiology

Volumn 590, Issue 11, 2012, Pages 2677-2691

  von der Weid, Pierre Yves ^a   Rehal, Sonia ^a   Dyrda, Peter ^a   Lee, Stewart ^a   Mathias, Ryan ^a   Rahman, Mozibur ^a   Roizes, Simon ^a   Imtiaz, Mohammad S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD VESSEL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GUINEA PIG; HYPERPOLARIZATION; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LYMPH VESSEL; LYMPH VESSEL PUMPING; MEMBRANE POTENTIAL; MESENTERY LYMPH NODE; MICROELECTRODE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VASODILATATION;

ANIMALS; GUINEA PIGS; LYMPHATIC VESSELS; MEMBRANE POTENTIALS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84861708893     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.230599     Document Type: Article

References (62)

1. Anaid S, Petkov V, Baykuscheva-Gentscheva T, Hoeger H, Painsipp E, Holzer P & Mosgoeller W (2007). Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery. Regul Pept 139, 102-108.
2. Benoit JN & Zawieja DC (1992). Effects of f-Met-Leu-Phe-induced inflammation on intestinal lymph flow and lymphatic pump behavior. Am J Physiol Gastrointest Liver Physiol 262, G199-G202.
3. Benoit JN, Zawieja DC, Goodman AH & Granger HJ (1989). Characterization of intact mesenteric lymphatic pump and its responsiveness to acute edemagenic stress. Am J Physiol Heart Circ Physiol 257, H2059-H2069.
4. Chan AK, Vergnolle N, Hollenberg MD & von der Weid P-Y (2004). Proteinase-activated receptor 2 modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity. J Physiol 560, 563-576.
5. Chan AK & von der Weid P-Y (2003). 5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors. Br J Pharmacol 139, 243-254.
6. Davies SP, Reddy H, Caivano M & Cohen P (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
7. Delgado M, Pozo D & Ganea D (2004). The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56, 249-290.
8. Dickinson T & Fleetwood-Walker SM (1999). VIP and PACAP: very important in pain? Trends Pharmacol Sci 20, 324-329.
9. Fahrenkrug J, Hannibal J, Tams J & Georg B (2000). Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J Cereb Blood Flow Metab 20, 1205-1214.
10. Flagg TP, Enkvetchakul D, Koster JC & Nichols CG (2010). Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 90, 799-829.
11. Fox JL & von der Weid P-Y (2002). Effects of histamine on the contractile and electrical activity in isolated lymphatic vessels of the guinea-pig mesentery. Br J Pharmacol 136, 1210-1218.
12. Gao J, Zhao J, Rayner SE & van Helden DF (1999). Evidence that the ATP-induced increase in vasomotion of guinea-pig mesenteric lymphatics involves an endothelium-dependent release of thromboxane A2. Br J Pharmacol 127, 1597-1602.
13. Gonzalez-Rey E & Delgado M (2007). Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders? Trends Pharmacol Sci 28, 482-491.
14. Grant S, Lutz EM, McPhaden AR & Wadsworth RM (2006). Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries. J Cereb Blood Flow Metab 26, 58-67.
15. Guarna M, Pucci AM, Alessandrini C, Volpi N, Fruschelli M, D'Antona D & Fruschelli C (1991). Peptidergic innervation of mesenteric lymphatics in guinea pigs: an immunocytochemical and pharmacological study. Lymphology 24, 161-167.
16. Hattori Y, Nagashima M, Endo Y & Kanno M (1992). Glibenclamide does not block arterial relaxation caused by vasoactive intestinal polypeptide. Eur J Pharmacol 213, 147-150.
17. Hosaka K, Rayner SE, von der Weid PY, Zhao J, Imtiaz MS & van Helden DF (2006). Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs. Am J Physiol Heart Circ Physiol 290, H813-H822.
18. 2+ stores interacting as coupled oscillators via membrane depolarization. Biophys J 92, 3843-3861.
19. Johnston MG (1987). Interaction of inflammatory mediators with the lymphatic vessel. Pathol Immunopathol Res 6, 177-189.
20. Jovanovic A, Jovanovic S, Tulic I & Grbovic L (1998). Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Mol Hum Reprod 4, 71-76.
21. + currents: effect of VIP in oesophagus. Br J Pharmacol 127, 553-561.
22. Kawasaki J, Kobayashi S, Miyagi Y, Nishimura J, Fujishima M & Kanaide H (1997). The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Br J Pharmacol 121, 977-985.
23. Kishi M, Takeuchi T, Katayama H, Yamazaki Y, Nishio H, Hata F & Takewaki T (2000). Involvement of cyclic AMP-PKA pathway in VIP-induced, charybdotoxin-sensitive relaxation of longitudinal muscle of the distal colon of Wistar-ST rats. Br J Pharmacol 129, 140-146.
24. + channels. Br J Pharmacol 119, 623-630.
25. Koller A, Mizuno R & Kaley G (1999). Flow reduces the amplitude and increases the frequency of lymphatic vasomotion: role of endothelial prostanoids. Am J Physiol Regul Integr Comp Physiol 277, R1683-R1689.
26. Laburthe M & Couvineau A (2002). Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regul Pept 108, 165-173.
27. Mizuno R, Koller A & Kaley G (1998). Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins. Am J Physiol Regul Integr Comp Physiol 274, R790-R796.
28. Moitra J, Sammani S & Garcia JG (2007). Re-evaluation of Evans Blue dye as a marker of albumin clearance in murine models of acute lung injury. Transl Res 150, 253-265.
29. Nelson MT & Quayle JM (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268, C799-C822.
30. Ohhashi T, Olschowka JA & Jacobowitz DM (1983). Vasoactive intestinal peptide inhibitory innervation in bovine mesenteric lymphatics. A histochemical and pharmacological study. Circ Res 53, 535-538.
31. Pozo D & Delgado M (2004). The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? FASEB J 18, 1325-1334.
32. Purves GI, Kamishima T, Davies LM, Quayle JM & Dart C (2009). Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels. J Physiol 587, 3639-3650.
33. + currents in smooth muscle cells from rabbit mesenteric artery. Am J Physiol Cell Physiol 269, C1112-C1118.
34. Quayle JM, Nelson MT & Standen NB (1997). ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77, 1165-1232.
35. + channel. Circ Res 94, 1359-1366.
36. Rehal S, Blanckaert P, Roizes S & von der Weid PY (2009). Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels. Br J Pharmacol 158, 1961-1970.
37. Rockson SG (2001). Lymphedema. Am J Med 110, 288-295.
38. + channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide. Mol Pharmacol 56, 955-961.
39. St Hilaire RC, Murthy SN, Kadowitz PJ & Jeter JR Jr (2010). Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation. Peptides 31, 1517-1522.
40. Scallan JP & Huxley VH (2010). In vivo determination of collecting lymphatic vessel permeability to albumin: a role for lymphatics in exchange. J Physiol 588, 243-254.
41. Shahbazian A, Petkov V, Baykuscheva-Gentscheva T, Hoeger H, Painsipp E, Holzer P & Mosgoeller W (2007). Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery. Regul Pept 139, 102-108.
42. Shi Y, Cui N, Shi W & Jiang C (2008). A short motif in Kir6.1 consisting of four phosphorylation repeats underlies the vascular KATP channel inhibition by protein kinase C. J Biol Chem 283, 2488-2494.
43. Shi Y, Wu Z, Cui N, Shi W, Yang Y, Zhang X, Rojas A, Ha BT & Jiang C (2007). PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol 293, R1205-R1214.
44. + channels in arterial smooth muscle. Science 245, 177-180.
45. Umarova BA, Lelekova TV, Kopylova GN, Goncharova EL, Bakaeva ZV & Samonina GE (2006). The role of protective effects of proline-containing peptides (PGP, PG, and GP) in contractile dysfunction of mesenteric lymphatic vessels in rats with experimental acute peritonitis. Bull Exp Biol Med 142, 279-282.
46. van Helden D (1993). Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery. J Physiol 471, 465-479.
47. + channels in smooth muscle cells of guinea-pig mesenteric lymphatics: role in nitric oxide and beta-adrenoceptor agonist-induced hyperpolarizations. Br J Pharmacol 125, 17-22.
48. von der Weid P-Y (2001). Lymphatic vessel pumping and inflammation - the role of spontaneous constrictions and underlying electrical pacemaker potentials. Aliment Pharmacol Ther 15, 1115-1129.
49. von der Weid P-Y, Crowe MJ & van Helden DF (1996). Endothelium-dependent modulation of pacemaking in lymphatic vessels of the guinea-pig mesentery. J Physiol 493, 563-575.
50. von der Weid P-Y, Lee S, Dyrda P, Rehal S, Roizes S & Imtiaz MS (2011). Inhibition of mesenteric lymphatic vessel pumping by the neuro-immuno-modulators VIP and PACAP. Inflam Res 60, S46 (abstract).
51. von der Weid P-Y, Rahman M, Imtiaz MS & van Helden DF (2008). Spontaneous transient depolarizations in lymphatic vessels of the guinea pig mesentery: pharmacology and implication for spontaneous contractility. Am J Physiol Heart Circ Physiol 295, H1989-H2000.
52. von der Weid P-Y, Rehal S & Dyrda P (2009). Characterization of VIP-induced contractile inhibition in lymphatic vessels. FASEB J 23, 764-765 (abstract).
53. von der Weid P-Y & van Helden DF (1997). Functional electrical properties of the endothelium in lymphatic vessels of the guinea-pig mesentery. J Physiol 504, 439-451.
54. von der Weid P-Y, Zhao J & van Helden DF (2001). Nitric oxide decreases pacemaker activity in lymphatic vessels of guinea pig mesentery. Am J Physiol Heart Circ Physiol 280, H2707-H2716.
55. Wang XY, Wong WC & Ling EA (1995). Ultrastructural localisation of substance P, vasoactive intestinal peptide and somatostatin immunoreactivities in the submucous plexus of guinea pig ileum. J Anat 186, 187-196.
56. Wathuta EM (1986). The distribution of vasoactive intestinal polypeptide-like, substance P-like and bombesin-like immunoreactivity in the digestive system of the sheep. Q J Exp Physiol 71, 615-631.
57. Wu TF, Carati CJ, Macnaughton WK & von der Weid PY (2006). Contractile activity of lymphatic vessels is altered in the TNBS model of guinea pig ileitis. Am J Physiol Gastrointest Liver Physiol 291, G566-G574.
58. Wu TF, MacNaughton WK & von der Weid PY (2005). Lymphatic vessel contractile activity and intestinal inflammation. Mem Inst Oswaldo Cruz 100, 107-110.
59. Yang Y, Shi Y, Guo S, Zhang S, Cui N, Shi W, Zhu D & Jiang C (2008). PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery. Biochim Biophys Acta 1778, 88-96.
60. Yokoyama S & Ohhashi T (1993). Effects of acetylcholine on spontaneous contractions in isolated bovine mesenteric lymphatics. Am J Physiol Heart Circ Physiol 264, H1460-H1464.
61. Zhang S, Liu Y, Guo S, Zhang J, Chu X, Jiang C & Zhu D (2010). Vasoactive intestinal polypeptide relaxes isolated rat pulmonary artery rings through two distinct mechanisms. J Physiol Sci 60, 389-397.
62. Zhong N & Zucker RS (2005). cAMP acts on exchange protein activated by cAMP/cAMP-regulated guanine nucleotide exchange protein to regulate transmitter release at the crayfish neuromuscular junction. J Neurosci 25, 208-214.